Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Vasculitis

From the College  |  Issue: October 2008  |  October 1, 2008

Vasculitis is a general term for a group of rare diseases that involve inflammation of blood vessels. There are many types of vasculitis, and the different diseases that fall under this term may vary significantly when it comes to symptoms, severity, and duration. Most forms of vasculitis are rare and affect both men and women of all ages.

The causes of most types of vasculitis are not known. However, some cases of vasculitis are directly caused by reactions to medications. Additionally, some chronic infections—particularly those caused by hepatitis C virus or hepatitis B virus—can cause vasculitis. No other environmental exposures have been convincingly demonstrated to lead to vasculitis.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

According to patient–fact sheet authors Paul A. Monach, MD, PhD, and Peter A. Merkel, MD, MPH, “Vasculitis can also be a part of several other rheumatic diseases—especially lupus, rheumatoid arthritis, and Sjögren’s syndrome. However, most patients with vasculitis have none of these underlying problems, and it is not hereditary.”

The wide range of symptoms seen in vasculitis reflects the potential for damage from poor blood flow to a variety of affected tissues throughout the body. For example, vasculitic damage to the lungs may cause shortness of breath and cough; damage to nerves may lead to numbness or weakness in a hand or foot; and damage to skin may produce red spots, nodules, or ulcers. On the other hand, vasculitis of the kidneys may produce no symptoms at onset but is quite a serious problem. Vasculitic diseases can be mild or life threatening and can range from a single episode to multiple episodes.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Physicians consider the possibility of vasculitis when a patient has symptoms, physical exam signs, or laboratory tests suggesting damage to one or more organ systems in the absence of another clear cause. Methods to diagnose vasculitis depend on the size of the vessel involved. Most patients can be diagnosed with a specific vasculitic disease based on the size of the affected blood vessels and the organs most commonly involved. However, for some patients, a specific type of vasculitis cannot be determined. A few forms of vasculitis can be diagnosed on the basis of a collection of clinical findings rather than biopsy or angiography.

Glucocorticoids, often referred to as steroids, are an important part of therapy for most forms of vasculitis, but dose and duration vary with the severity and chronicity of the disease. Other immunosuppressive agents are used either because the disease is so severe that glucocorticoids alone are insufficient treatment, or because the long-term side effects of these other drugs are less severe than those of glucocorticoids. Plasma exchange and intravenous immunoglobulin are sometimes used in severe cases of particular forms of vasculitis that are thought to be caused by circulating autoantibodies. Permanent damage from severe vasculitis can require surgical treatment, such as vascular bypass grafting, sinus surgery, or kidney transplantation.

Page: 1 2 | Single Page
Share: 

Filed under:ConditionsFrom the CollegeVasculitis Tagged with:Diagnostic CriteriaPatient Fact SheetVasculitis

Related Articles

    The Granulomatosis of Wegener’s

    May 16, 2011

    Delving deeper into the nonvasculitis aspects of the disease

    Case Report: A 40-Year-Old Man with Vasculitic Neuropathy

    Case Report: A 40-Year-Old Man with Vasculitic Neuropathy

    October 19, 2020

    Ironically, chronic exposure to minocycline has also been associated with a variety of autoimmune syndromes, including drug-induced lupus, auto­immune hepatitis, serum sickness and vasculitis.1 Minocycline is associated with an 8.5-fold increased risk of drug-induced lupus.2 Minocycline and nitrofurantoin are implicated in 90% of cases of drug-induced autoimmune hepatitis.3 Minocycline-induced vasculitis is much less common and,…

    ilusmedical / shutterstock.com

    The State of Clinical Research in Vasculitis: 2021

    January 19, 2021

    It is an exciting time in the world of vasculitis research. More clinical studies and trials are being conducted now than at any time in history. In the past ten years, four drugs have been approved by the U.S. Food & Drug Administration (FDA) and other regulatory agencies specifically for the treatment of vasculitis: Rituximab…

    Alisusha; Trueffelpix / shutterstock.com

    3 New Vasculitis Guidelines Discussed

    May 13, 2021

    The ACR, in concert with the Vasculitis Foundation, released three new vasculitis guidelines online first in July, with a fourth slated for publication by the end of the year. These are the first ever to be produced and endorsed by the ACR and the Vasculitis Foundation. Although most of the recommendations are conditional, due to…

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences